Algeria currently reports an pregnant women living with hiv antiretroviral therapy coverage for pmtct of 26%, which represents an increase of 3% (13.0%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Algeria
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Algeria
PMTCT antiretroviral therapy coverage
More indicators for Algeria
Algeria PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 26% | +3% |
| 2021 | 23% | -9% |
| 2020 | 32% | -13% |
| 2019 | 45% | +2% |
| 2018 | 43% | +6% |
| 2017 | 37% | +6% |
| 2016 | 31% | +13% |
| 2015 | 18% | -3% |
| 2014 | 21% | -21% |
| 2013 | 42% | +13% |
| 2012 | 29% | -6% |
| 2011 | 35% | -2% |
| 2010 | 37% | +14% |
| 2009 | 23% | -4% |
| 2008 | 27% | +27% |
| 2007 | 0% | 0% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |